المؤلفون: Jin Zhang, Jeffrey S. Weber, James R. Anderson, Anthony M. Joshua, Adil Daud, Scot Ebbinghaus, Richard F. Kefford, Richard W. Joseph, Amita Patnaik, Peter Hersey, Wen-Jen Hwu, Omid Hamid, Caroline Robert, Tara C. Gangadhar, Antoni Ribas, Scott J. Diede, F. Stephen Hodi, Hassane M. Zarour, Roxana S. Dronca, Jedd D. Wolchok

المصدر: Journal of Clinical Oncology. 36:1668-1674

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Skin Neoplasms, Pembrolizumab, Antibodies, Monoclonal, Humanized, Disease-Free Survival, law.invention, Cohort Studies, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Randomized controlled trial, law, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Carcinoma, Humans, Neoplasm Metastasis, Melanoma, Aged, business.industry, Middle Aged, medicine.disease, Discontinuation, Clinical trial, 030104 developmental biology, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Monoclonal, Female, business, Cohort study

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cc80c548aef4a43c6afca48a89a7e9fTest
https://doi.org/10.1200/jco.2017.75.6270Test

المؤلفون: Andrey Meshcheryakov, Alexander M.M. Eggermont, Christian U. Blank, Michal Kicinski, Ragini R. Kudchadkar, Victoria Atkinson, Nageatte Ibrahim, Mario Mandalà, Pablo L. Ortiz-Romero, Inge Marie Svane, Georgina V. Long, Catherine Barrow, Anna Maria Di Giacomo, Stefan Suciu, Alexander C.J. van Akkooi, Clemens Krepler, Rosalie Stephens, Caroline Robert, Shahneen Sandhu, Sandrine Marreaud

المصدر: Journal of Clinical Oncology. 39:9500-9500

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, business.industry, Pembrolizumab, Placebo, Complete resection, Stage III cutaneous melanoma, Gastroenterology, Oncology, Internal medicine, Medicine, Stage III melanoma, Lymph, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::b78b72df461dc1b73ea9d7b00a0cabf3Test
https://doi.org/10.1200/jco.2021.39.15_suppl.9500Test

المؤلفون: Jason Chesney, Mohammed M. Milhem, Marya F. Chaney, Wendy Snyder, Priya Gokani, Caroline Robert

المصدر: Journal of Clinical Oncology. 38:TPS10079-TPS10079

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, biology, business.industry, Melanoma, Anti pd 1, Pembrolizumab, medicine.disease, Oncolytic virus, Internal medicine, Programmed cell death 1, medicine, biology.protein, In patient, Talimogene laherparepvec, business, Advanced melanoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::020a015b3315e6d68ddf376a2653cb85Test
https://doi.org/10.1200/jco.2020.38.15_suppl.tps10079Test

المؤلفون: Jeffrey E. Gershenwald, Merrick I. Ross, Nageatte Ibrahim, Charles H. Yoon, Vernon K. Sondak, Jean-Jacques Grob, Piotr Rutkowski, John M. Kirkwood, Alexander M.M. Eggermont, Andrew Poklepovic, Jason J. Luke, Richard A. Scolyer, Georgina V. Long, Sama Ahsan, Peter Mohr, James R. Anderson, Matteo S. Carlino, Caroline Robert, Axel Hauschild, Paolo A. Ascierto

المصدر: Journal of Clinical Oncology. 37:TPS9596-TPS9596

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Pembrolizumab, Placebo, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Stage II melanoma, Adjuvant therapy, Medicine, In patient, Stage III melanoma, business, Adjuvant, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::dfd1a33d37748bae5890bfaca892ce80Test
https://doi.org/10.1200/jco.2019.37.15_suppl.tps9596Test

المؤلفون: Andrew G. Hill, Steven J. O'Day, Stéphane Dalle, Marcus O. Butler, Victoria Atkinson, Jonathan Cebon, Alexander M. Menzies, Blanca Homet Moreno, Steven L. McCune, Nageatte Ibrahim, Caroline Robert, Félix Couture, Matteo S. Carlino, Cuizhen Niu, Geoffrey T. Gibney, Georgina V. Long, Michael P. Brown, Adi Diab

المصدر: Journal of Clinical Oncology. 37:9514-9514

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Ipilimumab, Pembrolizumab, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Toxicity, Cohort, medicine, Nivolumab, business, 030215 immunology, Advanced melanoma, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2651b0497437c58c78ae468efd3b99d8Test
https://doi.org/10.1200/jco.2019.37.15_suppl.9514Test

المؤلفون: Mario Mandalà, Andrew Haydon, Stéphane Dalle, Matteo S. Carlino, Paolo A. Ascierto, Christian U. Blank, Victoria Atkinson, Muhammad A. Khattak, Michal Kicinski, Susana Puig, Mikhail Lichinitser, Alexander C.J. van Akkooi, Shahneen Sandhu, Alexander M.M. Eggermont, Stefan Suciu, Nageatte Ibrahim, Georgina V. Long, Clemens Krepler, Caroline Robert, Sandrine Marreaud

المصدر: Journal of Clinical Oncology. 37:2517-2517

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Pembrolizumab, Immunotherapy, Placebo, Predictive value, 03 medical and health sciences, 0302 clinical medicine, Immune system, 030220 oncology & carcinogenesis, Internal medicine, medicine, Stage III melanoma, business, Adverse effect, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::79a17e7e77f0a48b2afc7ced78dc55f9Test
https://doi.org/10.1200/jco.2019.37.15_suppl.2517Test

المؤلفون: Jean-Jacques Grob, Peter Mohr, Andrew Poklepovic, Richard A. Scolyer, Jason J. Luke, Vernon K. Sondak, Jeffrey E. Gershenwald, James R. Anderson, Matteo S. Carlino, Caroline Robert, John M. Kirkwood, Nageatte Ibrahim, Charles H. Yoon, Georgina V. Long, Alexander M.M. Eggermont, Sama Ahsan, Axel Hauschild, Paolo A. Ascierto, Merrick I. Ross

المصدر: Journal of Clinical Oncology. 37:TPS145-TPS145

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Pembrolizumab, Placebo, Stage II melanoma, Internal medicine, medicine, Adjuvant therapy, Stage III melanoma, business, Adjuvant

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::12cb82cf6dd4d9636fb43dbb994f2112Test
https://doi.org/10.1200/jco.2019.37.8_suppl.tps145Test

المؤلفون: Thomas F. Gajewski, Christian Caglevic, James R. Anderson, Tae Min Kim, Jean-Jacques Grob, Lev V. Demidov, Omid Hamid, Georgina V. Long, Ana Arance, Janet Maleski, Caroline Robert, Mark M. Jones, James Larkin, Stéphane Dalle, Matteo S. Carlino, Scott J. Diede, Reinhard Dummer, Tara C. Mitchell

المصدر: Journal of Clinical Oncology. 36:108-108

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, endocrine system diseases, Metastatic melanoma, business.industry, Melanoma, Pembrolizumab, medicine.disease, Placebo, digestive system diseases, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Toxicity, Medicine, In patient, Epacadostat, Stage (cooking), business, neoplasms

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ebd689ec9bbf832c22479f33e07d79ffTest
https://doi.org/10.1200/jco.2018.36.15_suppl.108Test

المؤلفون: Adil Daud, Erin Jensen, Jeffrey S. Weber, Caroline Robert, F. Stephen Hodi, Nageatte Ibrahim, Roxana S. Dronca, Hassane M. Zarour, Tara C. Mitchell, Omid Hamid, Sama Ahsan, Jedd D. Wolchok, Anthony M. Joshua, Wen-Jen Hwu, Antoni Ribas, Amita Patnaik, Richard F. Kefford, Peter Hersey, Richard W. Joseph

المصدر: Journal of Clinical Oncology. 36:9516-9516

مصطلحات موضوعية: 0301 basic medicine, Antitumor activity, Oncology, Cancer Research, medicine.medical_specialty, business.industry, Pembrolizumab, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Medicine, In patient, business, Advanced melanoma

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::3fbb047d8833d264e368a414e48c7c42Test
https://doi.org/10.1200/jco.2018.36.15_suppl.9516Test

المؤلفون: Christian U. Blank, Catriona M. McNeil, Matteo S. Carlino, Caroline Robert, Teresa M. Petrella, Blanca Hornet Moreno, Jean-Jacques Grob, Honghong Zhou, Michal Lotem, Jacob Schachter, Nageatte Ibrahim, Adil Daud, Georgina V. Long, Laurent Mortier, Bart Neyns, James Larkin, Ana Arance, Omid Hamid, Paul Lorigan, Antoni Ribas

المساهمون: Clinical sciences, Medical Oncology, Laboratory of Molecular and Medical Oncology, Laboratory of Molecullar and Cellular Therapy

المصدر: Robert, C, Long, G V, Schachter, J, Arance, A, Grob, J J, Mortier, L, Daud, A, Carlino, M S, McNeil, C M, Lotem, M, Larkin, J M G, Lorigan, P, Neyns, B, Blank, C U, Petrella, T M, Hamid, O, Zhou, H, Homet Moreno, B, Ibrahim, N & Ribas, A 2017, ' Long-term outcomes in patients (pts) with ipilimumab (ipi)-naive advanced melanoma in the phase 3 KEYNOTE-006 study who completed pembrolizumab (pembro) treatment. ', pp. 9504-9504 . https://doi.org/10.1200/jco.2017.35.15_suppl.9504Test

مصطلحات موضوعية: 0301 basic medicine, Tumor imaging, Oncology, Cancer Research, medicine.medical_specialty, Manchester Cancer Research Centre, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Ipilimumab, Pembrolizumab, Surgery, Discontinuation, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Long term outcomes, Medicine, In patient, business, Until Disease Progression, Advanced melanoma, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b0b36eb1cf26881f86cbd6ad665c2e3Test
https://doi.org/10.1200/jco.2017.35.15_suppl.9504Test